Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Yes, the efgartigimod delay was noted here; not welcome news but was not greeted with panic either.
Other negative issues are related patent durability and, recently, some glimmers of competition with the rHuph20 enzyme.
Helen's leadership is looking shakier than ever but my feeling is that the BOD is composed of people she has helped select, so no ope of a leadership change, despite the crying need for it.
I do hope and expect that Helen will be grilled on the next CC. It should be interesting.
Feel free to drop in on West Pharma and make a pitch for the buyout. LOL!!